Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.13
-0.17 (-3.21%)
Aug 29, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Novel Immunotherapies
7.69M
Log In
Log In
Log In
Log In
Upgrade
Novel Immunotherapies Growth
-2.36%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
7.69M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-2.36%
Log In
Log In
Log In
Log In
Upgrade